C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 25.05 PLN 0.2% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Celon Pharma SA?
Write Note

Celon Pharma SA
Investor Relations

Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The firm's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The firm is a subsidiary of Glatton sp z o o.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Maciej Wieczorek Ph.D.
CEO & President of Management Board
No Bio Available
Bartosz Szalek
CFO & Member of the Management Board
No Bio Available

Contacts

Address
WOJ. MAZOWIECKIE
ul. Ogrodowa 2A, Kielpin
Contacts
+48227515933
celonpharma.com